Co-infection with invasive pulmonary aspergillosis and Pneumocystis jirovecii pneumonia after corticosteroid therapy

Hideharu Hagiya, Takayoshi Miyake, Yusuke Kokumai, Tomoko Murase, Yasutoshi Kuroe, Hiroyoshi Nojima, Junichi Sugiyama, Hiromichi Naito, Shingo Hagioka, Naoki Morimoto

Research output: Contribution to journalArticle

5 Citations (Scopus)

Abstract

A 95-year-old man with chronic obstructive pulmonary disease and chronic hepatitis C virus infection was treated for acute lung injury caused by Chlamydophila pneumoniae with antibiotics and high-dose corticosteroids. In total, 7,500 mg methylprednisolone and 680 mg prednisolone were administered over 21 days. However, respiratory failure progressed, and chest computed tomography (CT) scan showed bilateral ground-glass opacity and cavity-forming consolidation in the right upper lobe. Despite intensive therapy, the patient died of multiple organ failure on day 7. CT-guided necropsy was performed, and pathological examination revealed invasive pulmonary aspergillosis and Pneumocystis jirovecii pneumonia. Invasive pulmonary aspergillosis and P. jirovecii pneumonia are both life-threatening opportunistic fungal infections. Co-infection of these organisms is rare but possible if the patient is in an extremely immunocompromised state. Short-term but high-dose systemic corticosteroid therapy was considered to be the risk factor in this case. We should pay more attention to immunocompromised hosts who might be suffering from co-infection of opportunistic infections. Moreover, we need to consider preventive measures in such high-risk cases.

Original languageEnglish
Pages (from-to)342-347
Number of pages6
JournalJournal of Infection and Chemotherapy
Volume19
Issue number2
DOIs
Publication statusPublished - Apr 2013
Externally publishedYes

Fingerprint

Invasive Pulmonary Aspergillosis
Pneumocystis carinii
Pneumocystis Pneumonia
Opportunistic Infections
Coinfection
Adrenal Cortex Hormones
Tomography
Chlamydophila pneumoniae
Multiple Organ Failure
Mycoses
Acute Lung Injury
Methylprednisolone
Immunocompromised Host
Chronic Hepatitis C
Virus Diseases
Prednisolone
Respiratory Insufficiency
Hepacivirus
Chronic Obstructive Pulmonary Disease
Glass

Keywords

  • Coinfection
  • Corticosteroid therapy
  • Invasive pulmonary aspergillosis
  • Opportunistic infection
  • Pneumocystis jirovecii pneumonia

ASJC Scopus subject areas

  • Microbiology (medical)
  • Pharmacology (medical)
  • Infectious Diseases

Cite this

Co-infection with invasive pulmonary aspergillosis and Pneumocystis jirovecii pneumonia after corticosteroid therapy. / Hagiya, Hideharu; Miyake, Takayoshi; Kokumai, Yusuke; Murase, Tomoko; Kuroe, Yasutoshi; Nojima, Hiroyoshi; Sugiyama, Junichi; Naito, Hiromichi; Hagioka, Shingo; Morimoto, Naoki.

In: Journal of Infection and Chemotherapy, Vol. 19, No. 2, 04.2013, p. 342-347.

Research output: Contribution to journalArticle

Hagiya, Hideharu ; Miyake, Takayoshi ; Kokumai, Yusuke ; Murase, Tomoko ; Kuroe, Yasutoshi ; Nojima, Hiroyoshi ; Sugiyama, Junichi ; Naito, Hiromichi ; Hagioka, Shingo ; Morimoto, Naoki. / Co-infection with invasive pulmonary aspergillosis and Pneumocystis jirovecii pneumonia after corticosteroid therapy. In: Journal of Infection and Chemotherapy. 2013 ; Vol. 19, No. 2. pp. 342-347.
@article{60fbad415be748c2bb44db9ab1379f2f,
title = "Co-infection with invasive pulmonary aspergillosis and Pneumocystis jirovecii pneumonia after corticosteroid therapy",
abstract = "A 95-year-old man with chronic obstructive pulmonary disease and chronic hepatitis C virus infection was treated for acute lung injury caused by Chlamydophila pneumoniae with antibiotics and high-dose corticosteroids. In total, 7,500 mg methylprednisolone and 680 mg prednisolone were administered over 21 days. However, respiratory failure progressed, and chest computed tomography (CT) scan showed bilateral ground-glass opacity and cavity-forming consolidation in the right upper lobe. Despite intensive therapy, the patient died of multiple organ failure on day 7. CT-guided necropsy was performed, and pathological examination revealed invasive pulmonary aspergillosis and Pneumocystis jirovecii pneumonia. Invasive pulmonary aspergillosis and P. jirovecii pneumonia are both life-threatening opportunistic fungal infections. Co-infection of these organisms is rare but possible if the patient is in an extremely immunocompromised state. Short-term but high-dose systemic corticosteroid therapy was considered to be the risk factor in this case. We should pay more attention to immunocompromised hosts who might be suffering from co-infection of opportunistic infections. Moreover, we need to consider preventive measures in such high-risk cases.",
keywords = "Coinfection, Corticosteroid therapy, Invasive pulmonary aspergillosis, Opportunistic infection, Pneumocystis jirovecii pneumonia",
author = "Hideharu Hagiya and Takayoshi Miyake and Yusuke Kokumai and Tomoko Murase and Yasutoshi Kuroe and Hiroyoshi Nojima and Junichi Sugiyama and Hiromichi Naito and Shingo Hagioka and Naoki Morimoto",
year = "2013",
month = "4",
doi = "10.1007/s10156-012-0473-9",
language = "English",
volume = "19",
pages = "342--347",
journal = "Journal of Infection and Chemotherapy",
issn = "1341-321X",
publisher = "Elsevier BV",
number = "2",

}

TY - JOUR

T1 - Co-infection with invasive pulmonary aspergillosis and Pneumocystis jirovecii pneumonia after corticosteroid therapy

AU - Hagiya, Hideharu

AU - Miyake, Takayoshi

AU - Kokumai, Yusuke

AU - Murase, Tomoko

AU - Kuroe, Yasutoshi

AU - Nojima, Hiroyoshi

AU - Sugiyama, Junichi

AU - Naito, Hiromichi

AU - Hagioka, Shingo

AU - Morimoto, Naoki

PY - 2013/4

Y1 - 2013/4

N2 - A 95-year-old man with chronic obstructive pulmonary disease and chronic hepatitis C virus infection was treated for acute lung injury caused by Chlamydophila pneumoniae with antibiotics and high-dose corticosteroids. In total, 7,500 mg methylprednisolone and 680 mg prednisolone were administered over 21 days. However, respiratory failure progressed, and chest computed tomography (CT) scan showed bilateral ground-glass opacity and cavity-forming consolidation in the right upper lobe. Despite intensive therapy, the patient died of multiple organ failure on day 7. CT-guided necropsy was performed, and pathological examination revealed invasive pulmonary aspergillosis and Pneumocystis jirovecii pneumonia. Invasive pulmonary aspergillosis and P. jirovecii pneumonia are both life-threatening opportunistic fungal infections. Co-infection of these organisms is rare but possible if the patient is in an extremely immunocompromised state. Short-term but high-dose systemic corticosteroid therapy was considered to be the risk factor in this case. We should pay more attention to immunocompromised hosts who might be suffering from co-infection of opportunistic infections. Moreover, we need to consider preventive measures in such high-risk cases.

AB - A 95-year-old man with chronic obstructive pulmonary disease and chronic hepatitis C virus infection was treated for acute lung injury caused by Chlamydophila pneumoniae with antibiotics and high-dose corticosteroids. In total, 7,500 mg methylprednisolone and 680 mg prednisolone were administered over 21 days. However, respiratory failure progressed, and chest computed tomography (CT) scan showed bilateral ground-glass opacity and cavity-forming consolidation in the right upper lobe. Despite intensive therapy, the patient died of multiple organ failure on day 7. CT-guided necropsy was performed, and pathological examination revealed invasive pulmonary aspergillosis and Pneumocystis jirovecii pneumonia. Invasive pulmonary aspergillosis and P. jirovecii pneumonia are both life-threatening opportunistic fungal infections. Co-infection of these organisms is rare but possible if the patient is in an extremely immunocompromised state. Short-term but high-dose systemic corticosteroid therapy was considered to be the risk factor in this case. We should pay more attention to immunocompromised hosts who might be suffering from co-infection of opportunistic infections. Moreover, we need to consider preventive measures in such high-risk cases.

KW - Coinfection

KW - Corticosteroid therapy

KW - Invasive pulmonary aspergillosis

KW - Opportunistic infection

KW - Pneumocystis jirovecii pneumonia

UR - http://www.scopus.com/inward/record.url?scp=84880700959&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84880700959&partnerID=8YFLogxK

U2 - 10.1007/s10156-012-0473-9

DO - 10.1007/s10156-012-0473-9

M3 - Article

C2 - 22965844

AN - SCOPUS:84880700959

VL - 19

SP - 342

EP - 347

JO - Journal of Infection and Chemotherapy

JF - Journal of Infection and Chemotherapy

SN - 1341-321X

IS - 2

ER -